Efficacy of combination therapy with amantadine, thymosin α1 and α/β interferon in mice infected with influenza a virus
- 29 February 1996
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 18 (2) , 95-102
- https://doi.org/10.1016/0192-0561(96)00002-1
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Antitumor Effect of Thymosin α1/Interleukin-2 or Thymosin α1/Interferon α,β Following Cyclophosphamide in Mice Injected with Highly Metastatic Friend Erythroleukemia CellsJournal of Immunotherapy, 1993
- Thymosin α 1 potentiates interleukin 2-induced cytotoxic activity in miceCellular Immunology, 1991
- Combination treatment using thymosin α1 and interferon after cyclophosphamide is able to cure Lewis lung carcinoma in miceCancer Immunology, Immunotherapy, 1990
- Synergistic effect of thymosin α1 and αβ-interferon on NK activity in tumor-bearing miceInternational Journal of Immunopharmacology, 1989
- Antiviral activity of a synthetic analog of prostaglandin A in mice infected with influenza A virusArchiv für die gesamte Virusforschung, 1988
- A Controlled Trial of Amantadine and Rimantadine in the Prophylaxis of Influenza a InfectionNew England Journal of Medicine, 1982
- Pulmonary and Systemic Defenses against Challenge with Staphylococcus aureus in Mice with Pneumonia Due to Influenza A VirusThe Journal of Infectious Diseases, 1979
- Cytotoxic T Cells in the Lungs of Mice Infected with an Influenza A VirusScandinavian Journal of Immunology, 1978
- Sensitivity of Influenza A/New Jersey/8/76 (HswlNl) Virus to AmantadinebulletHCIThe Journal of Infectious Diseases, 1977
- Two categories of lymphocyte unresponsiveness to phytohemagglutininCellular Immunology, 1973